What's Happening?
Three leading Parkinson's advocacy organizations are urging Congress to increase funding for Parkinson's research at the National Institutes of Health (NIH) as the President's federal budget proposal for Fiscal Year 2027 includes a $5 billion reduction
in NIH funding. The American Parkinson Disease Association, The Michael J. Fox Foundation for Parkinson's Research, and The Parkinson's Foundation are advocating for an annual investment of $600 million in Parkinson's research. This request comes as the economic burden of Parkinson's disease in the U.S. totals $82.2 billion annually. The organizations emphasize the importance of continued federal investment to support scientific breakthroughs and treatments for Parkinson's and related neurodegenerative diseases.
Why It's Important?
The proposed budget cuts to the NIH could significantly slow progress in Parkinson's research, affecting millions of Americans living with the disease. Increased funding is crucial for developing new treatments and potentially finding a cure. The advocacy groups highlight that federal investment has historically accelerated discoveries in neurodegenerative diseases, benefiting a broader scientific community. The call for increased funding is supported by a national survey indicating that three in four voters favor doubling federal investment in Parkinson's research. Maintaining robust NIH funding is essential for ongoing scientific discovery and public health advancements.
What's Next?
The advocacy groups have mobilized over 300 Parkinson's advocates from 49 states to share their experiences with Congress and push for increased NIH funding. They are prepared to support efforts to strengthen NIH funding through the appropriations process. The organizations aim to ensure that NIH remains central to the nation's investment in health and science, advocating for continued bipartisan support for scientific discovery. The outcome of these efforts will depend on Congress's response to the budget proposal and the advocacy groups' ability to influence legislative priorities.
